IceCure Medical Ltd (ICCM) vs Paranovus Entertainment Technology Ltd. (PAVS)
A side-by-side comparison of IceCure Medical Ltd and Paranovus Entertainment Technology Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ICCM
IceCure Medical Ltd
$1.30HealthcareDelayed quote: Oct 6, 2026, 3:59 PM EDT
PAVS
Paranovus Entertainment Technology Ltd.
$3.77HealthcareDelayed quote: Oct 6, 2026, 3:59 PM EDT
Total return — ICCM vs PAVS
growth of $100 · dividends reinvested · last 5yICCM -99.5% (-65.8%/yr)PAVS -100.0% (-93.2%/yr)ICCM compounded faster over this window
Log scale — wide-divergence pair
ICCM PAVS
ICCM vs PAVS: by the numbers
- •PAVS is the larger company ($3M vs $3M market cap).
- •Both run net losses; PAVS's is the smaller (-87.20% vs -427.67% net margin).
- •Both shrank revenue over the past five years; ICCM's decline was smaller (-0.69% vs -27.22% CAGR).
Metrics side by side
Valuation
| Metric | ICCM | PAVS |
|---|---|---|
| P/S ratio | 0.74 | N/A |
| P/B ratio | 0.25 | 0.10 |
Profitability
| Metric | ICCM | PAVS |
|---|---|---|
| Gross margin | 36.10% | 16.54% |
| Operating margin | -446.70% | -23.11% |
| Net margin | -427.67% | -87.20% |
| ROE | -141.90% | -40.75% |
| ROIC | -184.27% | -9.72% |
Growth (annualized)
| Metric | ICCM | PAVS |
|---|---|---|
| Revenue CAGR (5Y) | -0.69% | -27.22% |
| Total return CAGR (5Y) | -63.05% | -92.96% |
Frequently asked
- Which has grown faster, ICCM or PAVS?
- Neither grew: over the past five years both shrank revenue, with ICCM's decline the smaller — ICCM at a -0.69% CAGR versus PAVS at -27.22%.
- How have ICCM and PAVS total returns compared?
- Over the past 5 years, ICCM delivered -63.05% and PAVS delivered -92.96% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.